Latest filing published 11 Feb 2026 for Wave Life Sciences Ltd..
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Chandra Vargeese: trading record in brief
This profile gathers the share dealings of Chandra Vargeese in Wave Life Sciences Ltd. We count 27 filings; the first trade dates from 25 January 2017 and the latest from 9 February 2026.
Every open-market trade on record is a sale: 12 sales worth €762k. Outside the open market, there are 7 share grants and 8 option exercises. 2026 to date brings no purchases and 1 sale.
The newest entry dates from 11 February 2026: an open-market sale of €37k, in Wave Life Sciences Ltd. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Chandra Vargeese
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 45,625 shares0Ordinary SharesSEC:0001193125-26-047314:0
- 91,754 shares@ US$2.4838.5% of flowOrdinary SharesSEC:0000950170-25-033838:0
- 37,000 shares0Ordinary SharesSEC:0000950170-25-015679:0
- 46,000 shares@ US$2.4819.4% of flowOrdinary SharesSEC:0000950170-25-008909:0
- 68,210 shares@ US$2.4827.5% of flowOrdinary SharesSEC:0000950170-24-086173:0
- 10,249 shares@ US$4.036.9% of flowOrdinary SharesSEC:0000899243-23-005565:0
- 50,000 shares0Ordinary SharesSEC:0000899243-22-017136:0
- 10,603 shares@ US$2.324.0% of flowOrdinary SharesSEC:0000899243-22-007064:0
8 of 8 declarations
